News

Biosplice Licenses Development and Commercialization Rights for Lorecivivint, a Novel Phase 3 Osteoarthritis Drug Candidate, to Haisco for the People’s Republic of China

SAN DIEGO and CHENGDU, China, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering...

New study finds Perspectum’s LiverMultiScan may positively impact patient participation in liver disease care pathways

OXFORD, England--(BUSINESS WIRE)--#FattyLiver--Perspectum®’s LiverMultiScan® significantly enhanced patient understanding of chronic liver disease (CLD) care in a first-of-its-kind study published in...

error: Content is protected !!